Facts & Figures

Mycoplasma vaccines use either dead bacteria (inactivated) or live bacteria (attenuated strains). For the majority of mycoplasma infections, there is no effective commercial vaccine, which presents a problem not only to the European economy (e.g. M. bovis in cattle and M. agalactiae in sheep). There is an urgent need worldwide for new and better vaccines against Mycoplasma pathogens.